NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
- NHS England
Procurement identifier (OCID): ocds-h6vhtk-05838e
Description
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products - CM/PHR/22/5732
Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Notices
UK4: Tender notice
- Notice identifier
- 2025/S 000-057983
- Published
- 19 September 2025, 9:52am
UK2: Preliminary market engagement notice
- Notice identifier
- 2025/S 000-046995
- Published
- 7 August 2025, 3:21pm